Atul Ltd 2020-21

152 Atul Ltd | Annual Report 2020-21 Note 28.13 Loans Disclosures pursuant to the Regulation 34(3) read with para A of Schedule V to the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Section 186 (4) of the Companies Act, 2013: ( ` cr) Particulars Purpose Amount outstanding as at Maximum balance during the year March 31, 2021 March 31, 2020 2020-21 2019-20 i) Subsidiary companies: Amal Ltd Interest free loan, pursuant to Board for Industrial and Financial Reconstruction order - - - 6.28 Atul Bioscience Ltd Purchase of the manufacturing facility at Ambernath 24.00 17.50 24.00 17.50 ii) Joint operation of subsidiary company: Anaven LLP For working capital, operational and project expenditure requirement 6.85 - 6.85 - Notes: a) Loans given to employees as per the policy of the Company are not considered. b) The loanees did not hold any shares in the share capital of the Company. Note 28.14 Disclosure requirement under MSMED Act, 2006 The Company has certain dues to suppliers (trade and capital) registered under Micro, Small and Medium Enterprises Development Act, 2006 (‘MSMED Act’). The disclosures pursuant to the said MSMED Act are as follows: ( ` cr) Particulars As at March 31, 2021 As at March 31, 2020 Principal amount due to suppliers registered under the MSMED Act and remaining unpaid as at year end 23.41 6.88 Interest due to suppliers registered under the MSMED Act and remaining unpaid as at year end (current year: ` 123 and previous year: ` 460) Principal amounts paid to suppliers registered under the MSMED Act, beyond the appointed day during the year (current year: ` 9,251 and previous year: ` 42,745) Interest paid, other than under Section 16 of MSMED Act, to suppliers registered under the MSMED Act, beyond the appointed day during the year - - Interest paid, under Section 16 of MSMED Act, to suppliers registered under the MSMED Act, beyond the appointed day during the year (current year: ` 460) 0.01 Interest due and payable towards suppliers registered under MSMED Act, for payments already made - - Further interest remaining due and payable for earlier years - -